NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,562,475 | -7.4% | 238,700 | +1.9% | 0.01% | 0.0% |
| Q2 2023 | $11,401,038 | -8.2% | 234,300 | +4.8% | 0.01% | -11.1% |
| Q1 2023 | $12,414,272 | +24.3% | 223,600 | -10.1% | 0.01% | +28.6% |
| Q4 2022 | $9,986,262 | +5.0% | 248,600 | +14.6% | 0.01% | 0.0% |
| Q3 2022 | $9,509,000 | +25.5% | 217,000 | +1.5% | 0.01% | +40.0% |
| Q2 2022 | $7,574,000 | -7.5% | 213,700 | +6.2% | 0.01% | 0.0% |
| Q1 2022 | $8,189,000 | -52.8% | 201,300 | +8.4% | 0.01% | -50.0% |
| Q4 2021 | $17,343,000 | -11.0% | 185,700 | +6.2% | 0.01% | -16.7% |
| Q3 2021 | $19,491,000 | +0.4% | 174,900 | +2.3% | 0.01% | 0.0% |
| Q2 2021 | $19,414,000 | +15.3% | 171,000 | +3.1% | 0.01% | +9.1% |
| Q1 2021 | $16,835,000 | +10.2% | 165,800 | +8.0% | 0.01% | 0.0% |
| Q4 2020 | $15,276,000 | +38.5% | 153,500 | +0.5% | 0.01% | +22.2% |
| Q3 2020 | $11,031,000 | +49.5% | 152,700 | +3.2% | 0.01% | +50.0% |
| Q2 2020 | $7,379,000 | +134.7% | 148,000 | +40.6% | 0.01% | +100.0% |
| Q1 2020 | $3,144,000 | -0.6% | 105,300 | +12.1% | 0.00% | 0.0% |
| Q4 2019 | $3,163,000 | +5.2% | 93,900 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $3,008,000 | +35.5% | 91,700 | +13.9% | 0.00% | +50.0% |
| Q2 2019 | $2,220,000 | +47.1% | 80,500 | +10.0% | 0.00% | 0.0% |
| Q1 2019 | $1,509,000 | +54.5% | 73,200 | +4.6% | 0.00% | +100.0% |
| Q4 2018 | $977,000 | -33.0% | 70,000 | +14.9% | 0.00% | -50.0% |
| Q3 2018 | $1,458,000 | +27.2% | 60,900 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $1,146,000 | +158.1% | 60,900 | +27.1% | 0.00% | 0.0% |
| Q1 2018 | $444,000 | +16.8% | 47,900 | +13.2% | 0.00% | – |
| Q4 2017 | $380,000 | -30.3% | 42,300 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $545,000 | +18.7% | 42,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $459,000 | +22.4% | 42,300 | 0.0% | 0.00% | – |
| Q1 2017 | $375,000 | -24.2% | 42,300 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $495,000 | +5.3% | 42,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $470,000 | -7.8% | 42,300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $510,000 | – | 42,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |